December 30, 2025

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 55% Upside Potential in the Healthcare Sector

Pulse Biosciences, Inc (NASDAQ: PLSE) is generating buzz among investors with its promising position in the healthcare sector. Specializing in medical instruments and supplies, this Miami-based company is making waves..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a Potential 18.38% Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, is gaining attention for its promising stock performance and growth potential. With a market cap of $1.25 billion,..

GRAIL, Inc. (GRAL) Investor Outlook: Exploring a Potential 19.48% Upside in the Healthcare Diagnostics Sector

GRAIL, Inc. (NASDAQ: GRAL) has been making waves in the healthcare diagnostics sector with its innovative approach to multi-cancer early detection. As a commercial-stage company, GRAIL is at the forefront..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Promising 64.97% Upside Potential Draws Investor Attention

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering biotechnology company based in Cambridge, Massachusetts, is gaining significant traction among investors due to its innovative approach to developing precision genetic medicines. With..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: 55% Upside Potential Amidst Promising Drug Pipeline

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is carving out its niche in the biotechnology sector with a focus on muscle disorder therapies. With a market capitalization of $2.61 billion and a..

agilon health, inc. (AGL) Investor Outlook: Evaluating a 30.79% Potential Upside Amidst Challenging Valuations

agilon health, inc. (NYSE: AGL) is a company at the forefront of transforming healthcare delivery for seniors in the United States through its innovative platform that partners with primary care..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 73.56% Potential Upside in Medical Devices

Enovis Corporation (NYSE: ENOV) has emerged as a notable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.55 billion, Enovis is at..

AtriCure, Inc. (ATRC) Stock Analysis: A 29% Upside Potential with Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC) stands at the forefront of the healthcare sector, specifically within the medical instruments and supplies industry, where it continues to innovate in the realm of cardiac..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 27.79% Potential Upside Sparks Investor Interest

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing the attention of investors with its promising potential..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Navigating a 9.28% Potential Upside with Robust CNS Drug Pipeline

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) continues to capture investor attention with its strategic focus on developing and commercializing treatments for central nervous system (CNS) disorders and rare diseases. Based in..

Recursion Pharmaceuticals (RXRX): Investor Outlook with a 69% Potential Upside

In the bustling world of biotechnology, Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands out as a company blending technological prowess with drug discovery to address some of healthcare’s most challenging diseases...

Omnicell, Inc. (OMCL): Investor Outlook on a 11.62% Potential Upside in Healthcare Automation

Omnicell, Inc. (NASDAQ: OMCL), a pivotal player in the healthcare automation sector, offers intriguing investment opportunities with a projected potential upside of 11.62%. With a market capitalization of $2.12 billion..

NewAmsterdam Pharma (NAMS) Stock Analysis: Promising 36% Upside Potential Despite Current Challenges

NewAmsterdam Pharma Company N.V. (NAMS), a Netherlands-based biopharmaceutical firm, is drawing significant investor attention thanks to its innovative approach in the biotechnology sector. Specializing in the development of therapies targeting..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A Promising 39% Upside Potential Captures Investor Attention

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a key player in the biotechnology sector, is turning heads with a robust growth trajectory and a promising upside potential of 39.05%. With its innovative..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 175% Potential Upside in the Diagnostics & Research Sphere

Opko Health, Inc. (OPK) holds a unique position within the healthcare sector, particularly in the diagnostics and research industry. With its headquarters in Miami, Florida, Opko Health operates a diverse..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Biotechnology Innovator with Nearly 96% Upside Potential

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a key player in the biotechnology sector, is capturing investor attention with its innovative approach in treating retinal diseases and other eye conditions. Despite recent..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Promising 68.80% Upside Potential

Investors with an eye on the biotechnology sector may want to consider Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage company specializing in novel therapeutics for rare endocrine diseases. With a..

BGM Group Ltd. (BGM) Investor Outlook: Navigating a Downturn and Future Prospects

Investors in BGM Group Ltd. (BGM) might be intrigued by its unique position within the healthcare sector, specifically the drug manufacturers – specialty & generic industry in China. With a..

Artivion, Inc. (AORT) Stock Analysis: Unveiling an 11.62% Potential Upside in the Medical Device Sector

Artivion, Inc. (NYSE: AORT) stands out in the healthcare sector with its innovative medical devices and implantable human tissues. Headquartered in Kennesaw, Georgia, Artivion, formerly known as CryoLife, Inc., offers..

Evotec SE (EVO) Stock Analysis: Exploring a 77.69% Potential Upside with a Strong R&D Backbone

Evotec SE (EVO), a prominent player in the healthcare sector, specializes in drug discovery and development with operations spanning across the globe. Based in Hamburg, Germany, Evotec SE is classified..

Search

Funds

December 30, 2025

Search

Funds

December 30, 2025

FTSE 100

Funds